I knew this was coming, after how many people have gotten it?
The unusual
blood clotting disorder linked with Oxford-AstraZeneca’s
COVID-19 vaccine is a different kind of clotting problem, one that requires more extensive care, can’t be predicted and is “really kinda bad,” says a Toronto infectious diseases specialist. The case fatality rate ranges between 20 and 40 per cent.
For those reasons and more, Dr. Andrew Morris believes it’s time to halt AstraZeneca’s shots in Canada, except for people aged 40 or older living in hotspots with a high amount of disease activity and a high risk of infection, and only then if people face a two- to three-week delay in getting a Pfizer-BioNTech or Moderna shot — mRNA vaccines that haven’t been associated with the same blood clot “safety signal.”
'Very little excuse' to continue to use AstraZeneca in Canada: infectious diseases specialist